Administration of the TpoR agonist mimetic drug Eltrombopag resulted in enrichment of engineered cells when cultured alone, furthermore, we observed enhanced growth and survival of engineered cells in an in vitro model of tumour targeting of melanoma and ovarian cancer against matched autologous tumour lines. The gene discussed is MPL; the disease is neoplasm.